Biotech Has Momentum

 | Jan 09, 2012 | 10:53 AM EST  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

inhx

,

jazz

,

mdvn

,

qcor

,

achn

,

rptp

,

sppi

,

vhc

For the fourth straight day, dip-buyers are stepping up on early weakness. Once again, Europe is problematic and there are good reasons for profit-taking, but there are bids under the market and the bears must be a little worried about squeeze action.

On the momentum radar, biotechnology is the star of the show following news of a takeover of Inhibitex (INHX). Jazz Pharmaceuticals (JAZZ), which I mentioned Friday, is following through and other names, such as Medivation (MDVN), Questcor Pharmaceuticals (TICKER) and QCOR Pharmaceuticals (ACHN), are doing well.

I have my eye on a couple of small biotechs that have long bases and should attract breakout buyers if they can perk up a bit more. Raptor Pharmaceutical (RPTP), which has solid numbers, needs to get to the $6.50 level. Early volume looks good

Spectrum Pharmaceuticals (SPPI) has been sitting just under $15 for a few weeks and is seeing OK volume this morning.

VirnetX Holding (VHC), which I mentioned Friday and is my stock of the week, is seeing good buying in the early going and I'm looking for additional entry points.

As long as we hold the morning lows, the hot money will be looking for trades. My gut tells me that we are close to a correction, but I'm not going to do much on the short side until I see more aggressive selling and indications that the dip-buyers are backing off.

Columnist Conversations

1100 Handle May be Around the Corner
The action in the DOW today was the reverse of what we saw yesterday in the index. The rally off the lows in t...
The visualization of data is provided by Capital Market Laboratories (CML). Z is trading $115.95, down 2.8% w...
We are still seeing WYNN hold up above key WEEKLY support here, but I do want to show you what is in the way o...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.